Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: SRE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on SRE, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,773,357 SRE shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,773,357 shares
    Change vs previous 13F +50,765 shares

    3.01% of the 13F portfolio, value $164,407,928.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,722,592 shares
    Change vs previous 13F +121,007 shares

    3.22% of the 13F portfolio, value $167,384,265.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,601,585 shares
    Change vs previous 13F -76,366 shares

    2.97% of the 13F portfolio, value $141,414,542.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,677,951 shares
    Change vs previous 13F not available

    3.39% of the 13F portfolio, value $150,993,422.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).